|
Hepatitis B Drug Resistance Sequencing
|
|
General
|
| |
Clinical Use:
|
Testing for mutations associated with resistance to lamivudine, adefovir and entecavir used to treat hepatitis B infection. |
| |
Availability:
|
Results are usually available within 7 days of receipt by the testing laboratory. |
| |
|
| |
Code:
|
VHBDR |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
|
Collection Requirements
|
| |
Container:
|
EDTA with gel-PPT (PEARL), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
|
| |
Collection Instructions:
|
If sample will not reach laboratory within 24 hours of collection, it must be centrifuged and separated. |
Processing Requirements
|
| |
Alternate Containers:
|
|
|
|
|
Serum Sep. Tube-SST (GOLD) |
|
|
|
EDTA (LAVENDER) |
| |
Processing Instructions:
|
|
| |
Minimum Assay Volume:
|
250uL |
| |
Stability:
|
|
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Molecular Diagnostics |
Microbiology |
QEII Medical Centre |
6383 4402 |
|
Last Updated : 16-01-2024 11:11 |